Gian Life Care (BOM:542918) Long-Term Debt: ₹0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:542918 Gian Life Care Ltd BOM:542918
60 GF Score
Price ₹4.87
GF Value ₹5.80
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Gian Life Care Long-Term Debt?

Gian Life Care BOM:542918 +0.83% 60 Long-Term Debt is ₹0.00 Mil as of Dec. 2025. GuruFocus rates BOM:542918 with a GF Score™ of 60/100 and a GF Value™ of ₹5.80 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Gian Life Care's Long-Term Debt for the quarter that ended in Dec. 2025 was ₹0.00 Mil.

Gian Life Care's quarterly Long-Term Debt increased from Jun. 2025 (₹0.00 Mil) to Sep. 2025 (₹28.19 Mil) but then declined from Sep. 2025 (₹28.19 Mil) to Dec. 2025 (₹0.00 Mil).

Gian Life Care's annual Long-Term Debt increased from Mar. 2023 (₹16.50 Mil) to Mar. 2024 (₹22.83 Mil) and increased from Mar. 2024 (₹22.83 Mil) to Mar. 2025 (₹30.87 Mil).


Gian Life Care  (BOM:542918) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Gian Life Care Long-Term Debt Related Terms


Gian Life Care Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Gian Life Care's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gian Life Care Long-Term Debt Chart

Gian Life Care Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Long-Term Debt
Get a 7-Day Free Trial 6.20 18.72 16.50 22.83 30.87

Gian Life Care Quarterly Data
Sep20 Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 30.87 0.00 28.19 0.00
BOM:542918
60GF Score
Gian Life Care Ltd BOM:542918
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₹0.00 Mil mean?
Gian Life Care (BOM:542918) has a Long-Term Debt of ₹0.00 Mil as of Dec. 2025.
Is Gian Life Care's Long-Term Debt too high?
Gian Life Care's current Long-Term Debt is ₹0.00 Mil. Overall, Gian Life Care has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Gian Life Care's Long-Term Debt compare to TMO and DHR?
Gian Life Care's Long-Term Debt of ₹0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Diagnostics & Research company?
A good Long-Term Debt depends on the Medical Diagnostics & Research industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Gian Life Care's current Long-Term Debt is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gian Life Care stock overvalued right now?
Based on GuruFocus' analysis, Gian Life Care (BOM:542918) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹5.80, compared to a current price of ₹4.87 — trading 16% below its estimated fair value. The current Long-Term Debt is ₹0.00 Mil. Gian Life Care's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Gian Life Care (BOM:542918), the current Long-Term Debt is ₹0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gian Life Care (BOM:542918) Overvalued in 2026?

Based on GuruFocus' analysis, Gian Life Care stock appears to be undervalued. The current stock price of ₹4.87 is trading 16% below its estimated GF Value™ of ₹5.80. GuruFocus considers Gian Life Care to be Modestly Undervalued.

Key valuation signals for BOM:542918:

  • Long-Term Debt: ₹0.00 Mil
  • GF Value™: ₹5.80 vs. price of ₹4.87 (16% below fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the BOM:542918 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gian Life Care Business Description

Address 7/216 (6) Swaroop Nagar, Infront of L-L.R. Hospital, Kanpur, UP, IND, 208002
Gian Life Care Ltd is an Indian firm engaged in the business of providing diagnostic and related healthcare tests and services in Kanpur and nearby areas. The company provides a broad range of diagnostic and related healthcare tests and services such as patient diagnosis, prevention, and wellness diagnosis services to its patients and healthcare providers. Its customers include individual patients, hospitals, other healthcare providers, and corporate customers. Substantial revenue accrues from the Pathological Testing Fees. The company has only one operating segment namely, Laboratories Pathological Investigations.
60GF Score

Get the complete analysis for BOM:542918

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4.87
Price
₹5.80
GF Value